Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henk Struikmans

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Radiation Oncology (London, England)|February 28, 2014
Target volume delineation in breast conserving radiotherapy: are co-registered CT and MR images of added value?Mirjam Mast, Emile Coerkamp, Mark Heijenbrok, et al.
Anticancer Research|January 2, 2010
Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative studySherif Y El Sharouni, Henk B Kal, Angeliqué Barten-Van Rijbroek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 17, 2005
Interobserver variability of clinical target volume delineation of glandular breast tissue and of boost volume in tangential breast irradiationHenk Struikmans, Carla Wárlám-Rodenhuis, Tanja Stam, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2007
Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodesElena Musat, Philip Poortmans, Walter Van den Bogaert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2009
The influence of the use of CT-planning on the irradiated boost volume in breast conserving treatmentShafak Al Uwini, Ninja Antonini, Philip M Poortmans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2013
Left-sided breast cancer radiotherapy with and without breath-hold: does IMRT reduce the cardiac dose even further?Mirjam E Mast, Loes van Kempen-Harteveld, Mark W Heijenbrok, et al.
Breast (Edinburgh, Scotland)|August 18, 2018
Breast-conserving therapy for primary Ductal Carcinoma in Situ in The Netherlands: A multi-center study and population-based analysisJan J Jobsen, Luc J E E Scheijmans, Wilma G J M Smit, et al.
Journal of Clinical Epidemiology|April 18, 2022
Representativeness of trial participants: linking the EORTC boost-no boost trial to the Netherlands cancer registryAnouk Neven, Marissa C van Maaren, Kay Schreuder, et al.
The Breast Journal|June 6, 2019
An actualised population-based study on the use of radiotherapy in breast cancer patients in the NetherlandsKay Schreuder, Judith G Middelburg, Mieke J Aarts, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2011
MRI- versus CT-based volume delineation of lumpectomy cavity in supine position in breast-conserving therapy: an exploratory studyMarina Giezen, Erik Kouwenhoven, Astrid N Scholten, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Radiation Oncology (London, England)|February 28, 2014
Target volume delineation in breast conserving radiotherapy: are co-registered CT and MR images of added value?Mirjam Mast, Emile Coerkamp, Mark Heijenbrok, et al.
Anticancer Research|January 2, 2010
Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative studySherif Y El Sharouni, Henk B Kal, Angeliqué Barten-Van Rijbroek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 17, 2005
Interobserver variability of clinical target volume delineation of glandular breast tissue and of boost volume in tangential breast irradiationHenk Struikmans, Carla Wárlám-Rodenhuis, Tanja Stam, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2007
Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodesElena Musat, Philip Poortmans, Walter Van den Bogaert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2009
The influence of the use of CT-planning on the irradiated boost volume in breast conserving treatmentShafak Al Uwini, Ninja Antonini, Philip M Poortmans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2013
Left-sided breast cancer radiotherapy with and without breath-hold: does IMRT reduce the cardiac dose even further?Mirjam E Mast, Loes van Kempen-Harteveld, Mark W Heijenbrok, et al.
Breast (Edinburgh, Scotland)|August 18, 2018
Breast-conserving therapy for primary Ductal Carcinoma in Situ in The Netherlands: A multi-center study and population-based analysisJan J Jobsen, Luc J E E Scheijmans, Wilma G J M Smit, et al.
Journal of Clinical Epidemiology|April 18, 2022
Representativeness of trial participants: linking the EORTC boost-no boost trial to the Netherlands cancer registryAnouk Neven, Marissa C van Maaren, Kay Schreuder, et al.
The Breast Journal|June 6, 2019
An actualised population-based study on the use of radiotherapy in breast cancer patients in the NetherlandsKay Schreuder, Judith G Middelburg, Mieke J Aarts, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2011
MRI- versus CT-based volume delineation of lumpectomy cavity in supine position in breast-conserving therapy: an exploratory studyMarina Giezen, Erik Kouwenhoven, Astrid N Scholten, et al.
Pageof 7